itraconazole has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, D; Chan, A; Cuche, M; Fajutrao, L; Fredrikson, S; Henry, N; Lowin, J; McLeod, E; Perard, R; Pitcher, A | 1 |
| Anyanwu, EC; Campbell, AW; Vojdani, A | 1 |
2 other study(ies) available for itraconazole and Demyelinating Diseases
| Article | Year |
|---|---|
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Topics: Adjuvants, Immunologic; Cost-Benefit Analysis; Demyelinating Diseases; Humans; Infusions, Subcutaneous; Interferon beta-1a; Interferon-beta; Itraconazole; Markov Chains; Multiple Sclerosis, Relapsing-Remitting; Sweden; Treatment Outcome | 2013 |
Combination of high-dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.
Topics: Adult; Antifungal Agents; Autoantibodies; Chronic Disease; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Exposure; Evoked Potentials, Visual; Female; Fungi; Humans; Immunoglobulins, Intravenous; Itraconazole; Mycotoxins; Optic Neuritis | 2003 |